ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.869,36
0,78%
S&P 500
5.305,73
1,13%
Dow Jones
39.889,38
0,84%
Euro vs US Dollar
1,0879
0,60%
Bitcoin
66.082,54
7,38%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. TFF Pharmaceuticals Inc (TFFP)

  7. TFF Pharmaceuticals Inc (TFFP) News

TFFP

TFF Pharmaceuticals (TFFP)

TFF Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TFFP
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
14/05/202422h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
07/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
19/12/202312h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
15/12/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
13/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
08/12/202322h52Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TFFPTFF Pharmaceuticals Inc
08/12/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202323h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202323h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202323h25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
22/11/202323h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
21/11/202322h41Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TFFPTFF Pharmaceuticals Inc
14/11/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322h10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322h07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322h07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TFFPTFF Pharmaceuticals Inc
22/09/202322h16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
18/09/202323h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
18/09/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
17/08/202322h01GlobeNewswire Inc.TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionNASDAQ:TFFPTFF Pharmaceuticals Inc
16/08/202322h43Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202314h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202314h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202312h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202312h00GlobeNewswire Inc.TFF Pharmaceuticals Prices $5 Million Public Offering of Common StockNASDAQ:TFFPTFF Pharmaceuticals Inc
14/08/202322h12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
14/08/202322h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
27/06/202312h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TFFPTFF Pharmaceuticals Inc
23/06/202323h19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TFFPTFF Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TFFP

Kürzlich von Ihnen besucht

EU
IPR
Impresa Sgps
ASX
HEA
Health Corp
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten